Review of the epidemiology of overactive bladder

被引：113
作者：
Eapen, Renu S. [1 ]
Radomski, Sidney B. [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Div Urol, Toronto Western Hosp, Toronto, ON, Canada
来源：
RESEARCH AND REPORTS IN UROLOGY | 2016年 / 8卷
关键词：
overactive bladder; prevalence; sex; LUTS; BPH; quality of life;
D O I：
10.2147/RRU.S102441
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Overactive bladder (OAB) is common in both men and women. It is a symptom complex that causes significant detriment to quality of life in patients. Although the prevalence of OAB is similar in both sexes, there are sex-specific differences in individual symptoms and the impact on quality of life. The coexistence of benign prostatic hyperplasia with OAB can worsen quality of life in men. This review examines the major studies that looked at the epidemiology of OAB as it relates to both sexes. It focuses on both the overall prevalence rates and the incidence of individual symptoms. This paper also addresses the level of bother and quality of life in men and women with OAB. In addition, the relationship between OAB and benign prostatic hyperplasia is reviewed.
引用
收藏
页码：71 / 76
页数：6
相关论文
共 20 条
  • [1] Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
    Abrams, P
    Kaplan, S
    Gans, HJD
    Millard, R
    [J]. JOURNAL OF UROLOGY, 2006, 175 (03) : 999 - 1004
  • [2] Abrams P, 2006, J UROLOGY, V175
  • [3] Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration
    Chapple, Christopher R.
    Herschorn, Sender
    Abrams, Paul
    Wang, Joseph T.
    Brodsky, Marina
    Guan, Zhonghong
    [J]. BJU INTERNATIONAL, 2010, 106 (09) : 1332 - 1338
  • [4] National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age
    Coyne, Karin S.
    Sexton, Chris C.
    Vats, Vasudha
    Thompson, Christine
    Kopp, Zoe S.
    Milsom, Ian
    [J]. UROLOGY, 2011, 77 (05) : 1081 - 1087
  • [5] The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction
    de Nunzio, C
    Franco, G
    Rocchegiani, A
    Iori, F
    Leonardo, C
    Laurenti, C
    [J]. JOURNAL OF UROLOGY, 2003, 169 (02) : 535 - 539
  • [6] Do Patient Characteristics Predict Responsiveness to Treatment of Overactive Bladder With Antimuscarinic Agents?
    Herschorn, Sender
    Kaplan, Steven A.
    Sun, Franklin
    Ntanios, Fady
    [J]. UROLOGY, 2014, 83 (05) : 1023 - 1029
  • [7] Understanding the elements of overactive bladder: questions raised by the EPIC study
    Irwin, Debra E.
    Abrams, Paul
    Milsom, Ian
    Kopp, Zoe
    Reilly, Kate
    [J]. BJU INTERNATIONAL, 2008, 101 (11) : 1381 - 1387
  • [8] Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study
    Irwin, Debra E.
    Milsom, Ian
    Hunskaar, Steinar
    Reilly, Kate
    Kopp, Zoe
    Herschorn, Sender
    Coyne, Karin
    Kelleher, Con
    Hampel, Christian
    Artibani, Walter
    Abrams, Paul
    [J]. EUROPEAN UROLOGY, 2006, 50 (06) : 1306 - 1315
  • [9] Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving a-blocker treatment for lower urinary tract symptoms
    Kaplan, Steven A.
    Roehrborn, Claus G.
    Gong, Jason
    Sun, Franklin
    Guan, Zhonghong
    [J]. BJU INTERNATIONAL, 2012, 109 (12) : 1831 - 1840
  • [10] Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder
    Lee, JY
    Kim, HW
    Lee, SJ
    Koh, JS
    Suh, HJ
    Chancellor, MB
    [J]. BJU INTERNATIONAL, 2004, 94 (06) : 817 - 820
12